Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori - A randomized, double-blind comparison of a three times daily and twice daily regimen

European Journal of Gastroenterology and Hepatology

Volumn 9, Issue 11, 1997, Pages 1091-1095

  Goh, Khean Lee ^a   Parasakthi, N ^a   Chuah, Seong York ^a   Toetsch, Martin ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Amoxycillin; Bacterial resistance; Eradication; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; FAMOTIDINE; METRONIDAZOLE; UREASE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG ERUPTION; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; LETHARGY; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT COMPLIANCE; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TASTE DISORDER; TREATMENT OUTCOME; VERTIGO; XEROSTOMIA;

EID: 0030697489     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199711000-00012     Document Type: Article

References (25)

1. NIH Consensus Conference: Helicobacter pylori in peptic ulcer disease. JAMA 1994, 272:65-71.
2. International Agency for Research on Cancer: Schistosomes, liver flukes and Helicobacter pylori. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61. Lyon, France: IARC; 1994.
3. Megraud F: H. pylori resistance to antibiotics. In Helicobacter pylori - Basic Mechanism to Clinical Cure. Edited by Hunt RH, Tytgat GNJ. Dordrecht: Kluwer Academic Publishers; 1994:570-583.
4. Goh KL, Parasakthi N, Peh SC, et al.: Rapid urease test in the diagnosis of Helicobacter pylori infection. Singapore Med J 1994, 35:161-162.
5. Performance Standards for antimicrobial susceptibility testing; Fifth Informational Supplements. NCCLS Document M100-S5 (ISBN 1-56238-249-7) 1994. NCCLS, 771 East Lancaster Avenue, Villanova, Pennsylvania 19085.
6. Hentschel E, Brandstatter G, Dragosics B, et al.: Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993, 328:308-312.
7. Axon ATR: Helicobacter pylori therapy: effect on peptic ulcer disease. In Helicobacter pylori: Causal Agent in Peptic Ulcer Disease? Working party report to the World Congress of Gastroenterology, Sydney 1990. J Gastroenterol Hepatol 1991, 6:131-137.
8. Chiba N, Rao BV, Rademaker JW, et al.: Meta-analysis of the efficacy of antibiotic therapy in eradication of Helicobacter pylori. Am J Gastroenterol 1992, 87:1716-1727.
9. Tytgat GNJ: Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994, 8:359-368.
10. Tytgat GNJ, Noach LA: H. pylori eradication. In Helicobacter pylori - Basic Mechanism to Clinical Cure. Edited by Hunt RH, Tytgat GNJ. Dordrecht: Kluwer Academic Publishers; 1994:550-569.
11. Xia HX, Daw MA, Sant S, et al.: Clinical efficacy of triple therapy in Helicobacter pylori associated duodenal ulcer. Eur J Gastroenterol Hepatol 1993, 5:141-145.
12. Thys JC, Zwet AA, Moolennar W, et al.: Triple therapy versus amoxicillin plus omeprazole for the treatment of Helicobacter pylori infection. Am J Gastroenterol 1996, 91:93-97.
13. de Boer WA, Thys JC, Borody TJ, et al.: Proposal for use of a standard side-effect scoring system in studies exploring H. pylori treatment regimes. Eur J Gastroenterol Hepatol 1996, 8:641-643.
14. Parasakthi N, Goh KL: Metronidazole resistance among Helicobacter pylori strains in Malaysia [letter]. Am J Gastroenterol 1992, 87:808.
15. Ling TKW, Cheng AFB, Sung JJY, et al.: Metronidazole-resistant Helicobacter pylori in a five year study. Helicobacter 1996, 1:57-61.
16. Noach LA, Bertola MA, Schwartz MP, et al.: Treatment of Helicobacter pylori infection: an evaluation of various therapeutic trials. Eur J Gastroenterol Hepatol 1994, 6:585-591.
17. Rautelin H, Seppala K, Renkonen OV, et al.: Role of metronidazole resistance in therapy of Helicobacter pylori. Antimicrob Agents Chemother 1992, 36:163-166.
18. Bell GD, Powell K, Burridge SM, et al.: Experience with 'triple' anti-Helicobacter pylori therapy: side-effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resistance. Aliment Pharmacol Therap 1992, 4:427-435.
19. Burette A, Glupczynski Y, De Prez C: Evaluation of various multi-drug eradication regimens for Helicobacter pylori. Eur J Gastroenterol Hepatol 1992, 4:817-823.
20. Bazzoli F, Zagari RM, Fossi S, et al.: Efficacy and tolerability of a short term, low-dose triple therapy for eradication of Helicobacter pylori [abstract]. Gastroenterology 1993, 104:A140.
21. Logan RPH, Gummett PA, Misiewicz JJ, et al.: One-week eradication regimen for Helicobacter pylori. Lancet 1991, 338:1249-1252.
22. Bazzoli F, Zagari RM, Fossi S, et al.: Short term, low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994, 6:773-777.
23. Labenz J, Stolte M, Ruhl GH, et al.: One-week low dose triple therapy for cure of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1994, 7:9-11.
24. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al.: Eradication of Helicobacter pylori using one week triple therapies combining omeprazole with two antimicrobials. The MACH 1 study. Helicobacter 1996, 1:138-144.
25. Misiewicz JJ, Harris AW, Bardhan KD, et al.: One-week low-dose triple therapy for eradication of H. pylori. a large multicentre randomised trial. Gut 1996, 38(suppl. 1 ):A1.